Free tool
FAERS Monitor: Adrenaclick
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020800 or its brand name (Adrenaclick, Epinephrine). Reports on generic versions are filed under their own applications.
Reports
42,335
Serious
26,333
62% of reports
Hospitalization
13,996
Death reported
3,545
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,536
- headache3,074
- sinusitis2,919
- fatigue2,801
- product dose omission issue2,780
- pain2,488
- covid-192,424
- dyspnoea2,269
- nausea2,230
- pneumonia2,076
- off label use2,065
- inappropriate schedule of product administration1,785
- nasopharyngitis1,682
- pyrexia1,658
- urinary tract infection1,591
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 133 |
| 2005 | 118 |
| 2006 | 136 |
| 2007 | 166 |
| 2008 | 194 |
| 2009 | 269 |
| 2010 | 261 |
| 2011 | 702 |
| 2012 | 425 |
| 2013 | 301 |
| 2014 | 411 |
| 2015 | 635 |
| 2016 | 1,057 |
| 2017 | 1,572 |
| 2018 | 2,477 |
| 2019 | 3,337 |
| 2020 | 6,460 |
| 2021 | 3,909 |
| 2022 | 3,582 |
| 2023 | 3,781 |
| 2024 | 4,431 |
| 2025 | 4,735 |
| 2026 | 3,240 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,824 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| sinusitisSignal | 2,919 | 14.5 | 14.0 | 35,907 |
| covid-19Signal | 2,424 | 6.9 | 6.7 | 12,265 |
| inappropriate schedule of product administrationSignal | 1,785 | 5.0 | 4.7 | 5,632 |
| product dose omission issueSignal | 2,780 | 4.7 | 4.6 | 8,216 |
| urinary tract infectionSignal | 1,591 | 4.7 | 4.4 | 4,577 |
| nasopharyngitisSignal | 1,682 | 4.6 | 4.4 | 4,679 |
| pneumoniaSignal | 2,076 | 3.2 | 3.1 | 3,166 |
| headacheSignal | 3,074 | 2.4 | 2.4 | 2,686 |
| pyrexiaSignal | 1,658 | 2.4 | 2.3 | 1,351 |
| painSignal | 2,488 | 2.0 | 1.9 | 1,307 |
| dyspnoea | 2,269 | 2.0 | 1.9 | 1,152 |
| fatigue | 2,801 | 1.8 | 1.7 | 1,010 |
| drug ineffective | 4,536 | 1.7 | 1.7 | 1,429 |
| nausea | 2,230 | 1.4 | 1.3 | 265 |
| off label use | 2,065 | 1.2 | 1.1 | 54 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.